INTRODUCTION
The use of antenatal steroids and the administration of exogenous surfactant to infants with respiratory distress syndrome have had a significant impact on overall survival in very low birth weight (VLBW) infants. [1] [2] [3] Reports suggest improved survival in extremely low birth weight (ELBW) infants r750 g birth weight in the postsurfactant era. Trials of administration of exogenous surfactant have reported decreased mortality from respiratory distress syndrome in the ELBW group. 4 Owing to the persistence of a high rate of disability accompanying increased survival rates in ELBW infants, questions regarding their optimal early acute management remain. [5] [6] [7] [8] How long and how hard should the NICU team strive to achieve survival of these tiniest infants? 9, 10 Should the substantial costs involved be a consideration in these decisions at all? [9] [10] [11] [12] Balancing the potential long-term benefits and risks of acute interventions is often difficult in the early stages of serious illness in ELBW infants. Acute interventions with CPR and the use of continuous intravenous epinephrine infusion (IV EPI) are accepted clinical practice in the management of critically ill neonates, despite a lack of clinical studies supporting their use.
In contrast to results of CPR in full-term infants, successful outcome after CPR is unlikely in VLBW infants, whether necessary at birth or later. [9] [10] [11] [12] [13] [14] In VLBW infants, it is suggested that the timing of events precipitating CPR influence the likelihood of its success. 9, 10 Recent multicentre data report a 64% survival rate after delivery room CPR in infants 501-1500 g. 15 While the efficacy of IV EPI as an inotrope has been demonstrated in animal models 16 there remain scant data on its use in the human neonate. [17] [18] [19] Nevertheless, use of IV EPI has become accepted in clinical practice in the care of postoperative cardiac infants and is increasingly used in management of hypotension in other newborns.
The purpose of this study was to determine whether two specific acute interventions, CPR and IV EPI, provided in the NICU, were associated with survival in a population of infants r750 g birth weight managed in a tertiary care NICU in the postsurfactant era.
METHODS
We performed a retrospective case review study of all infants weighing r750 g birthweight, admitted to the University of Alberta Hospitals level III NICU for intensive care between January 1, 1990 and December 31, 1994 inclusive. Subsequent records could not be included due to changes in the demographics of perinatal care in this region. The two investigators reviewed all the case records. For study purposes CPR was defined as the requirement for initiation of chest compressions and administration of bolus dose IV epinephrine in infants receiving intensive care in the NICU. Events initiating CPR use were either ''precipitate''; when a discrete clinical event leading to CPR was clearly documented such as, endotracheal tube displacement or obstruction, pneumothorax, pneumopericardium, aspiration and pulmonary hemorrhage, or ''progressive''; when there was absence of a clear precipitating cause. The use of CPR in the clinical setting was in accordance with the American Heart Association, Neonatal Resuscitation Program guidelines. 16 Hypotension was defined as a blood pressure mean below the 10th percentile for a given gestation. 20 Inotropes were standardly administered with dopamine as first-line therapy and epinephrine commenced when first-line agents had failed. During the study period all infants with respiratory distress syndrome received exogenous surfactant.
The following clinical data were collected on all infants: (a) birthweight, gestational age, gender, major medical complications, (b) severity of illness score was calculated using the clinical risk index for babies (CRIB), 21 (c) number of episodes of CPR and classification of the initiating events, (d) the use of IV EPI infusion as an inotrope and the maximal dose administered; (e) length of hospital stay and discharge status. Neurodevelopmental status was assessed at 2 years of age using the Bayley Scales of Infant Development. 22 
ANALYSES
Statistical analyses were performed using Instat (Graphpad Software Inc). Differences between groups were examined using the Student's t-test and the Mann-Whitney U-test where normality test failed. Proportions and trends were examined using the Fisher's exact test and w 2 trend analysis. Statistical significance was set at p<0.05. All descriptive data are presented as mean±standard deviation unless otherwise stated. Ethical approval was obtained from the University of Alberta research ethics board.
RESULTS
Over the 5-year study period, 91 ELBW infants r750 g birthweight who received intensive care were identified. The mean birthweight was 632±82 g, median gestational age 24 weeks (range 22 to 32), mean CRIB score 12.1±4.4 and male:female ratio, 1.17:1.0. Of the 91 infants, 35 survived to discharge (38.5%, 95% confidence intervals 28.5 to 49.3). During the study period, antenatal steroids were administered to 37.5% of the infants, 28.6% were transported postnatally and did not receive steroids, for 33% of cases there was no clear documentation in the chart of steroid administration. Exogenous surfactant was administered to 74.7% of infants; of the remaining infants 23% had minimal respiratory disease and therefore did not receive surfactant and 2.3% did not require any respiratory support. The incidence of major medical complications in all the study infants are summarized in Table 1 . There were no differences demonstrated in the rate of complications between infants who received CPR and/or IV EPI and those who did not.
Cardiopulmonary Resuscitation
In all, 15 infants were identified as having received CPR on 16 occasions (one infant received CPR twice). All infants who received CPR were intubated and ventilated at the time of the event or very shortly afterwards. Data on the 15 infants who received CPR and the 76 remaining infants are presented in Table 2 . Birthweight, gestational age, gender ratio and major medical complications were similar in the two groups. CRIB scores were significantly higher (14.3±4.6) (p ¼ 0.03) in the CPR group than in the remaining infants (11.6±4.25). Six episodes of documented CPR were classified as ''precipitate'' and 10 were classified as ''progressive''. A total of 10 infants survived the CPR episode on a short-term basis. None of the infants who received CPR following either a precipitate or progressive event survived to discharge. In contrast, 35 of the 76 ELBW infants who did not receive CPR survived to discharge (p ¼ 0.0003). Epinephrine Infusions A total of 47 infants received IV EPI by continuous infusion. In general, use of IV EPI increased over the study period (Figure 1 ,
. Birthweight, gestational age, gender ratio, CRIB scores and medical complications did not differ significantly between the 47 infants who received IV EPI infusions and the remaining 44 infants (Table 3) . Survival rate to discharge was significantly lower (10/47) Figure 2 . A significant trend of decreased survival with increasing dose of IV EPI (p ¼ 0.027) was observed. None of the infants who received IV EPI at Z1.0 mcg/kg/minute survived to discharge.
Neurodevelopmental outcome data were obtained for 34/35 surviving infants. Disability rates were high in all the survivors with 53% having a Mental Development Index <70. No significant differences occurred in the rate of disability between infants who did and did not receive IV EPI. Details of the specific disabilities identified are summarized in Table 4 .
DISCUSSION
In this study, we questioned the assumption of improved survival following two specific invasive interventions CPR and continuous IV EPI infusion, in ELBW infants weighing r750 g managed in a single tertiary care facility.
We elected to study infants of birthweight r750 g, as they represent a population in whom controversy persists as to the longterm benefits and risks of very aggressive management in the early neonatal period. 23, 24 We did not examine episodes of delivery room CPR, as the etiology of these events is likely more reflective of antenatal problems. The definitions we applied in this study for both CPR and the etiology of events leading to it were similar to previously published studies. 8, 10 In contrast to reported data, 7, 8, 12 no difference in survival in relation to the event initiating CPR was demonstrated. Despite initial success in resuscitation, none of the infants in our study who received CPR survived to discharge. The differences between 
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No Epinephrine Figure 1 . Use of epinephrine infusions in infants r750 g birthweight by year during the study period. our results and other studies may reflect the small numbers in our study, a likely difference in severity of illness due to the lower birthweight in our infants and the difficulties in retrospectively describing CPR events. Reports of CPR in the delivery room are likely to produce different results to those from NICU for similar reasons. In a major study of CPR in infants <1500 g birthweight (VLBW), Lantos et al. 7 suggested that the use of CPR in VLBW infants was futile and should be considered experimental. However, these data were obtained from a population of larger infants in the presurfactant era. Our data continue to suggest that the use of CPR in the NICU is futile for infants r750 g birthweight.
In adult critical care patients with septic shock, IV EPI infusion increases cardiac index and mean arterial pressure without significant detrimental effect on pulmonary artery pressure or systemic vascular resistance. 25 In a neonatal animal model, IV EPI increases systemic arterial pressure and cardiac output under normoxic conditions, without affecting pulmonary vascular resistance. 26 Nevertheless, few data exist in standard pediatric critical care texts or the research literature on the clinical efficacy or outcome after IV EPI infusion to support arterial pressure and cardiac output in neonates and children. [13] [14] [15] At our NICU, the use of IV EPI as an inotrope in the management of ELBW infants became accepted in clinical practice over the 5-year study period ( Figure 1 ). As our attending neonatologists had extensive experience with IV EPI use in the management of neonatal cardiac surgical patients, this local clinical experience appears to have been extrapolated to the ELBW population, with a steady increase in IV EPI use despite the absence of supportive studies. We failed to find a difference in population characteristics or major medical complications between the ELBW infants who did and did not receive IV EPI. The lack of survival after higher doses of IV EPI may represent ''continuous cardiac resuscitation'' in dying infants. The uncontrolled use of IV EPI during the study period highlights the need for new therapies to be assessed critically. The presence of some survivors in the lower dose IV EPI range suggests the need for a prospective randomized trial to assess this treatment. While we have demonstrated no obvious benefit to survival associated with the use of high-dose IV EPI in ELBW infants its use does not appear to have been unduly harmful to survivors with no increase in the incidence of either major medical complications or of neurodevelopmental disabilities. However, by prolonging the dying process in nonsurvivors, this therapy may indeed be detrimental.
The outcome of ''survival to hospital discharge'' was chosen not as a measure of the immediate cardiovascular effects of CPR or IV EPI, but to reflect a benefit to these patients. Unfortunately, despite positive immediate cardiovascular effects, our results failed to demonstrate improved survival to discharge with CPR or high-dose IV EPI. This outcome measure allows us to avoid some of the controversy surrounding the concept of futility relating to intensive care treatment. 27 Long-term neurodevelopmental outcome in the survivors was unaffected by IV EPI administration with a similar high incidence of neurological problems in both groups. Our findings suggest a need to assess critically the clinical and ethical validity of the widespread current use of routine CPR and the administration of high-dose IV EPI in infants r750 g birthweight in NICU. Lantos et al. 7 suggest that physicians' obligations involve the protection of vulnerable patients against nonvalidated, ineffective or experimental treatments. Despite the report of ELBW survivors of delivery room CPR, 9 these results should not be automatically applied to CPR in the NICU. Populations of patients have been described in which aggressive intervention does not confer outcome benefit and patient advanced health care directives address the issue of future treatments in circumstances where benefit to hospital discharge is minimal or absent. 17, 28, 29 Guidelines exist governing the approach to borderline viable fetuses and high-risk newborn infants. 18, 19 A similar approach could be developed to protect ELBW infants against futile interventions in the NICU.
In common with other similar studies, our results have limitations. These data reflect practice at a single tertiary center and numbers are limited. Data collection was performed retrospectively, with accuracy therefore dependent upon initial correct documentation. Our results, however, reconfirm previous findings of high mortality following CPR in ELBW infants and document very poor survival following high-dose IV EPI infusion in this population. With the increased use of antenatal steroids survival rates for infants r750 g have improved significantly; however, mortality remains significant and poor neurodevelopmental outcome is an ongoing source of concern. [4] [5] [6] We should continue to critically assess risks and benefits of treatment interventions in this very high-risk group prior to adopting therapies as ''standard care''.
We have not addressed the financial implications for resource allocation in NICU resulting from these treatments because the primary focus of this study was survival. In addition, in Canada there is a single government payer healthcare delivery system thereby removing the financial burden from individual families. Concerns about the very high costs of supporting borderline viable infants may contribute towards an ''attitude of nonresuscitation''. 30 Our results should not be used in support of disguising cost control as futility, but to draw attention to the goals of specific treatments in NICU.
CONCLUSION
Our study examines the use of CPR and IV EPI in ELBW infants in a tertiary NICU during the postsurfactant era. The outcome for infants r750 g birthweight following CPR or IV EPI in our NICU is extremely poor and suggests that extreme caution be used in applying these treatments in these infants. Current standard clinical approaches within the NICU on the use of ''routine CPR'' and high-dose IV EPI in ELBW infants should be critically reassessed.
